Ningxia Zhongke Biotechnology Co., Ltd. (600165.SS) SHH

Currency In CNY

AD

Valuation

Market Cap6.7B
Enterprise Value6.25B
P/E Ratio-12.56
PEG Ratio-0.1
Price/Sales Ratio4.06
Price/Book Ratio3.89
Enterprise/Revenue5.31
Enterprise/EBITDA-95.45

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin-0.19
Operating Margin-0.23
AD

Management Effectiveness

Return On Assets-0.04
Return On Equity-0.17

Income Statement

Revenue444.48M
Revenue/Share0.29
Gross Profit-88.7M
EBITDA-2.73M
Net Income-90.38M
Diluted EPS-0.06

Balance Sheet

Total Cash272.49M
Total Cash/Share0.17
Total Debt861.27M
Total Debt/Equity0.75
Current Ratio2.71
Book Value Per Share0.79

Price History

52-Week Change-37.61
52-Week High4.85
52-Week Low2.63
Moving Average 50 Days3.15
Moving Average 200 Days3.65

Statistics

Average Volume7.3M
Shares Outstanding685.59M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio-0.03
Last Split Factor5:2
Last Split DateOctober 12, 2015
AD